The Obesity Pathway Innovation Programme (OPIP) was launched to explore innovative approaches to support individuals living with obesity across the UK. Backed by up to £85 million in funding from the UK government and Eli Lilly, the programme aims to test and expand new models of care through local pharmacies and community-based services.
IQVIA & Roczen are supporting NHS organisations to design, deliver, evaluate and secure funding for innovative obesity pathways. Combining industry-leading, clinically led digital weight management services with world-class health data and clinical research expertise to accelerate the development of scalable, evidence-based services.
Not only can we support with the delivery of pathways, but also to secure the funding needed to make them a reality.